Novel human prostate-specific cDNA: Molecular cloning, expression, and immunobiology of the recombinant protein

Biochemical and Biophysical Research Communications

Volumn 297, Issue 5, 2002, Pages 1075-1084

  Naz, Rajesh K ^a   Santhanam, Ramasamy ^a   Tyagi, Neetu ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

Benign prostatic hyperplasia; Postate antigens; Prostate cancer; Prostate cancer cell lines; Prostate genes

Indexed keywords

AMINO ACID; ANTIBODY; ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; DNA FRAGMENT; HISTIDINE; PEPTIDE; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA BASE; DIFFERENTIAL DISPLAY; DNA SEQUENCE; EXPRESSION VECTOR; GENE EXPRESSION; GENE FUSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; HYDROPHILICITY; IMMUNOBIOLOGY; MALE; MOLECULAR CLONING; MOLECULAR WEIGHT; NORTHERN BLOTTING; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TISSUE SPECIFICITY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL DIVISION; CELL MEMBRANE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE LIBRARY; HUMANS; HYPERPLASIA; MALE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RABBITS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; UP-REGULATION;

ORYCTOLAGUS CUNICULUS;

EID: 0036402470     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02349-5     Document Type: Article

References (37)

1. M.M. Ahmed, C.T. Lee, J.E. Oesterling, Current trends in the epidemiology of prostatic diseases: benign hyperplasia and adenocarcinoma, in: R.K. Naz (Ed.), Prostate: Basic and Clinical Aspects, CRC Press, Boca Raton, FL, 1997, pp. 3-25.
2. S.L. Parker, T. Tong, S. Bolden, P.A. Wingo, Cancer statistics, Cancer J. Clin. 47 (1997) 5-27.
3. E.A. Herness, R.K. Naz, Prostate-specific genes: present status and future direction, Front. Biosci. 6 (2001) d1083-1088.
4. M.A. Rees, M.I. Resnick, J.E. Oesterling, Use of prostate-specific antigen, Gleason score, and digital rectal examination in staging patients with newly diagnosed prostate cancer, Urol. Clin. N. Am. 24 (1997) 379-388.
5. A. Lundwall, H. Lilja, Molecular cloning of human prostate specific antigen cDNA, FEBS Lett. 214 (1987) 317-322.
6. B.F. Hankey, E.J. Feuer, L.X. Clegg, R.B. Hayes, J.M. Legler, P.C. Prorok, L.A. Ries, R.M. Merrill, R.S. Kaplan, Cancer surveillance series: interpreting trends in prostate cancer part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates, J. Natl. Cancer Inst. 91 (1999) 1017-1024.
7. E.J. Feuer, R.M. Merrill, B.F. Hankey, Cancer surveillance series: interpreting trends in prostate cancer part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality, J. Natl. Cancer Inst. 91 (1999) 1025-1032.
8. R. Etzioni, J.M. Legler, E.J. Feuer, R.M. Merrill, K.A. Cronin, B.F. Hankey, Cancer surveillance series: interpreting trends in prostate cancer part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality, J. Natl. Cancer Inst. 91 (1999) 1033-1039.
9. R.J. Ablin, A retrospective and prospective overview of prostate-specific antigen, J. Cancer Res. Clin. Oncol. 123 (1997) 583-594.
10. A.M. Herrala, K.S. Porvari, A.P. Kyllonen, P.T. Vihko, Comparison of human prostate-specific glandular kallikrein 2 and prostate-specific antigen gene expression in prostate with gene amplification and overexpression of prostate-specific glandular kallikrein 2 in tumor tissue, Cancer 92 (2001) 2975-2984.
11. R. Carter, A. Feldman, J. Coyle, Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase, Proc. Natl. Acad. Sci. USA 93 (1996) 749-753.
12. W.D.W. Heston, Biologic implications for prostatic function following identification of prostate-specific membrane antigen as a novel folate hydrolase/neurocarboxypeptidase, in: R.K. Naz (Ed.), Prostate: Basic and Clinical Aspects, CRC Press, Boca Raton, FL, 1997, pp. 267-298
13. R. Shen, Z.-Z. Su, C. Olsson, P.B. Fisher, Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display, Proc. Natl. Acad. Sci. USA 92 (1995) 6778-6782.
14. M.J. Bussemakers, A. van Bokhoven, G.W. Verhaegh, F.P. Smit, H.F. Karthaus, J.A. Schalken, F.M. Debruyne, N. Ru, W.B. Isaacs, DD3: a new prostate-specific gene, highly overexpressed in prostate cancer, Cancer Res. 59 (1999) 5975-5979.
15. V. Srikantan, Z. Zou, G. Petrovics, L. Xu, M. Augustus, L. Davis, J.R. Livezey, T. Connell, I.A. Sesterhenn, K. Yoshino, G.S. Buzard, F.K. Mostofi, D.G. McLeod, J.W. Moul, S. Srivastava, PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer, Proc. Natl. Acad. Sci. USA 97 (2000) 12216-12221.
16. R. Reiter, Z. Gu, T. Watabe, G. Thomas, K. Szigeti, E. Davis, M. Wahl, S. Nisitani, J. Yamashiro, B.M. Le, M. Loda, O. Witte, Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer, Proc. Natl. Acad. Sci. USA 95 (1998) 1735-1740.
17. W.W. He, P.J. Sciavolino, J. Wing, M. Augustus, P. Hudson, P.S. Meissner, R.T. Curtis, B.K. Shell, D.G. Bostwick, D.J. Tindall, E.P. Gelmann, C. Abate-Shen, K.C. Carter, A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer, Genomics 43 (1997) 69-77.
18. Oettgen, E. Finger, Z. Sun, Y. Akbarali, U. Thamrongsak, J. Boltax, F. Grall, A. Dube, A. Weiss, L. Brown, G. Quinn, K. Kas, G. Endress, C. Kunsch, T.A. Libermann, PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression, J. Biol. Chem. 275 (2000) 1216-1225.
19. P. Nelson, L. Gan, C. Ferguson, P. Moss, R. Gelinas, L. Hood, K. Wang, Molecular cloning and characterization of prostate, an androgen-regulated serine protease with prostate-restricted expression, Proc. Natl. Acad. Sci. USA 96 (1999) 3114-3119.
20. A. Paolini-Giacobino, H. Chen, M.C. Peitsch, C. Rossier, S.E. Antonarakis, Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3, Genomics 44 (1997) 309-320.
21. R. Santhanam, R.K. Naz, Novel human testis-specific cDNA: molecular cloning, expression, and immunobiological effects of the recombinant protein, Mol. Reprod. Dev. 60 (2001) 1-12.
22. R.K. Naz, X. Zhu, A.L. Kadam, Cloning and sequencing of cDNA encoding for a novel human testis-specific contraceptive vaccinogen: role in immunocontraception, Mol. Reprod. Dev. 60 (2001) 116-127.
23. F. Sanger, S. Nicklen, A.R. Coulson, DNA sequencing with chain-terminating inhibitors, Proc. Natl. Acad. Sci. USA 74 (1997) 5463-5467.
24. J. Kyte, R.F. Doolittle, A simple method for displaying the hydropathic character of a protein, J. Mol. Biol. 157 (1982) 105-132.
25. D.M. Engelman, T.A. Steitz, A. Goldman, Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins, Annu. Rev. Biochem. Biophys. 15 (1986) 321-353.
26. S.F. Altschul, W. Gish, W. Miller, E.W. Myers, D.J. Lipman, Basic local alignment search tool, J. Mol. Biol. 215 (1990) 403-410.
27. R.K. Naz, X. Zhu, A.L. Kadam, Identification of human sperm peptide sequence involved in egg binding for immunocontraception, Biol. Reprod. 62 (2000) 318-324.
28. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685.
29. H. Towbin, T. Stachelin, J. Gordon, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. USA 76 (1979) 4350-4354.
30. X. Zhu, R.K. Naz, Fertilization antigen-1: cDNA cloning, testis-specific expression, and immunocontraceptive effects, Proc. Natl. Acad. Sci. USA 94 (1997) 4704-4709.
31. Y.K. Kwon, N.B. Hecht, Binding of a phosphoprotein to the 3′ untranslated region of the mouse protamine 2 mRNA temporally represses its translation, Mol. Cell. Biol. 3 (1993) 6547-6557.
32. K.E. Matlack, W. Mothes, T.A. Rapoport, Protein translocation: tunnel version, Cell 92 (1998) 381-390.
33. G. von Heijne, The signal peptide, J. Membr. Biol. 115 (1990) 195-201.
34. M.G. Low, Glycosyl-phosphatidylinositol: a versatile anchor for cell surface proteins, Fed. Am. Soc. Exp. Biol. J. 3 (1989) 1600-1608.
35. T. Pawson, Protein modules and signaling network, Nature 373 (1995) 573-580.
36. M.S. Steiner, Peptide growth factors in prostate cancer, in: R.K. Naz (Ed.), Prostate: Basic and Clinical Aspects, CRC Press, Boca Raton, FL, 1997, pp. 151-179.
37. K.J. Pienta, R. Panvichian, Current and future therapies for prostate cancer, in: R.K. Naz (Ed.), Prostate: Basic and Clinical Aspects, CRC Press, Boca Raton, FL, 1997, pp. 345-359.